Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease-Reference-Cited by-同舟云学术

Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease

Published:2019-06-10 Issue:6 Volume:11 Page:1175-1190
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Benschop Robert J.¹^ORCID,Chow Chi-Kin¹,Tian Yu¹,Nelson James²,Barmettler Barbra²^ORCID,Atwell Shane²^ORCID,Clawson David³^ORCID,Chai Qing²^ORCID,Jones Bryan²^ORCID,Fitchett Jon²,Torgerson Stacy⁴,Ji Yan^ORCID,Bina Holly¹,Hu Ningjie¹^ORCID,Ghanem Mahmoud^ORCID,Manetta Joseph¹,Wroblewski Victor J.⁴,Lu Jirong¹,Allan Barrett W.²

Affiliation:

1. Biotechnology Discovery Research, Lilly Research Laboratories, Eli Lilly and Company Corporate Center, Indianapolis, IN, USA

2. Biotechnology Discovery Research, Applied Molecular Evolution, Eli Lilly and Company, San Diego, CA, USA

3. Discovery Chemistry Research and Technologies, Eli Lilly and Company Corporate Center, Indianapolis, IN, USA

4. Department of Drug Disposition Development/Commercialization; Lilly Research Laboratories, Eli Lilly and Company Corporate Center, Indianapolis, IN, USA

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2019.1624463

Reference67 articles.

1. Bispecific antibody pipeline moves beyond oncology

2. Developmental Toxicity and Fertility Assessment in Rabbits with Tabalumab: A Human IgG4 Monoclonal Antibody

3. BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth

4. Baff and Rheumatic Autoimmune Disorders: Implications for Disease Management and Therapy

5. Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developability considerations for bispecific and multispecific antibodies;mAbs;2024-08-27

2. Precision engineering of antibodies: A review of modification and design in the Fab region;International Journal of Biological Macromolecules;2024-08

3. Preclinical efficacy of peanut-specific IgG4 antibody therapeutic IGNX001;Journal of Allergy and Clinical Immunology;2024-07

4. A case study of a bispecific antibody manufacturability assessment and optimization during discovery stage and its implications;Antibody Therapeutics;2024-05-29

5. Role of autoreactive Tc17 cells in the pathogenesis of experimental autoimmune encephalomyelitis;Neuroprotection;2024-03